A carregar...
Abrogated AID function prolongs survival and diminishes renal pathology in the BXSB mouse model of SLE
Almost a decade has passed since the approval of belimumab, a monoclonal antibody directed against B lymphocyte stimulation and the first targeted therapy approved for systemic lupus erythematous (SLE) in over 50 years. While well tolerated, the efficacy of belimumab remains limited and is not label...
Na minha lista:
| Publicado no: | J Immunol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7033011/ https://ncbi.nlm.nih.gov/pubmed/31988182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1900501 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|